Literature DB >> 15539317

Beneficial effects of gamma linolenic acid supplementation on nerve conduction velocity, Na+, K+ ATPase activity, and membrane fatty acid composition in sciatic nerve of diabetic rats.

T Coste1, M Pierlovisi, J Leonardi, D Dufayet, A Gerbi, H Lafont, P Vague, D Raccah.   

Abstract

Metabolic and vascular abnormalities are implicated in the pathogenesis of diabetic neuropathy. Two principal metabolic defects are altered lipid metabolism resulting from the impairment of delta-6-desaturase, which converts linoleic acid (LA) into gamma linolenic acid (GLA), and reduced nerve Na+, K+ ATPase activity. This reduction may be caused by a lack of incorporation of (n-6) fatty acids in membrane phospholipids. Because this ubiquitous enzyme maintains the membrane electrical potential and allows repolarization, disturbances in its activity can alter the process of nerve conduction velocity (NCV). We studied the effects of supplementation with GLA (260 mg per day) on NCV, fatty acid phospholipid composition, and Na+, K+ ATPase activity in streptozotocin-diabetic rats. Six groups of 10 rats were studied. Two groups served as controls supplemented with GLA or sunflower oil (GLA free). Two groups with different durations of diabetes were studied: 6 weeks with no supplementation and 12 weeks supplemented with sunflower oil. To test the ability of GLA to prevent or reverse the effects of diabetes, two groups of diabetic rats were supplemented with GLA, one group for 12 weeks and one group for 6 weeks, starting 6 weeks after diabetes induction. Diabetes resulted in a 25% decrease in NCV (P < 0.0001), a 45% decrease in Na+, K+ ATPase activity (P < 0.0001), and an abnormal phospholipid fatty acid composition. GLA restored NCV both in the prevention and reversal studies and partially restored Na+, K+ ATPase activity in the preventive treatment group (P < 0.0001). These effects were accompanied by a modification of phospholipid fatty acid composition in nerve membranes. Overall, the results suggest that membrane fatty acid composition plays a direct role in NCV and confirm the beneficial effect of GLA supplementation in diabetic neuropathy.

Entities:  

Year:  1999        PMID: 15539317     DOI: 10.1016/s0955-2863(99)00020-0

Source DB:  PubMed          Journal:  J Nutr Biochem        ISSN: 0955-2863            Impact factor:   6.048


  7 in total

1.  Effect of alloxan diabetes and subsequent insulin treatment on temperature kinetics properties of succinate oxidase activity in rat kidney mitochondria.

Authors:  Samir P Patel; Surendra S Katyare
Journal:  J Membr Biol       Date:  2007-03-08       Impact factor: 1.843

2.  Insulin-status-dependent modulation of FoF1-ATPase activity in rat liver mitochondria.

Authors:  Samir P Patel; Surendra S Katyare
Journal:  Lipids       Date:  2006-07       Impact factor: 1.880

Review 3.  The Potential Role of Fatty Acids in Treating Diabetic Neuropathy.

Authors:  Mark A Yorek
Journal:  Curr Diab Rep       Date:  2018-08-25       Impact factor: 4.810

4.  Omega-6 and omega-3 fatty acids predict accelerated decline of peripheral nerve function in older persons.

Authors:  F Lauretani; S Bandinelli; B Bartali; B Benedetta; A Cherubini; A D Iorio; A Blè; V Giacomini; A M Corsi; J M Guralnik; L Ferrucci
Journal:  Eur J Neurol       Date:  2007-07       Impact factor: 6.089

5.  Insulin status-dependent alterations in lipid/phospholipid composition of rat kidney microsomes and mitochondria.

Authors:  Samir P Patel; Surendra S Katyare
Journal:  Lipids       Date:  2006-09       Impact factor: 1.646

6.  Polyphenols of marine red macroalga Symphyocladia latiuscula ameliorate diabetic peripheral neuropathy in experimental animals.

Authors:  Suman Samaddar; Raju Koneri
Journal:  Heliyon       Date:  2019-05-20

7.  Effect of Early and Late Interventions with Dietary Oils on Vascular and Neural Complications in a Type 2 Diabetic Rat Model.

Authors:  Lawrence Coppey; Eric Davidson; Hanna Shevalye; Alexander Obrosov; Mark Yorek
Journal:  J Diabetes Res       Date:  2019-08-07       Impact factor: 4.011

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.